Commonality is rare
CriticalCare = Yes
Incidence is approximately 1 in 100,000 people
Coagulation Factor Assay (Blood Clotting Factors)
Erythrocyte Fragility Test (Osmotic Fragility, OF)
Free Erythrocyte Protoporphyrin (FEP) Concentration
Glucose 6 Phosphate Dehydrogenase (G6PD) Concentration
Partial Pressure of Arterial Carbon Dioxide (PCO2, PaCO2)
Protein Electrophoresis (Blood, Serum Protein)
Autoimmune haemolytic anaemia (abbreviated to AIHA) actually refers to a group of disorders characterised by a defect of the immune system, wherein autoantibodies attack and destroy red blood cells as though they were harmful foreign substances in the bloodstream.
AIHA is an uncommon group of disorders, and can affect individuals of an age, although women tend to be at greater risk. In approximately half of cases, the cause of AIHA remains unidentified. The disorders are also known to accompany other disorders, as well as the use of certain drugs. Destruction of the red blood cells can occur spontaneously, or over a longer period of time.